JD Supra Corporate Brief: China Detentions, HIPAA Policies, Compounding Pharmacies, Club Deals

Sign up for email delivery of the JD Supra Corporate Brief, and you’ll never go hungry for reading material again!

The key lesson for multinationals from China’s arrest and detention of four GSK employees? Update your anti-corruption programs… (K&L Gates)

Worried that the Supreme Court’s ruling against “pay to delay” agreements in Actavis could expose you to antitrust scrutiny? It’s unlikely… (Howard Ullman)

Federal judge reviewing a Deferred Prosecution Agreement: “I am not a potted plant…” (Jeff Ifrah)

You’ve got two months to get your HIPAA privacy policies up to date… (Ogletree Deakins)

FINRA wants to know how high frequency traders regulate their algorithms… (Shipkevich)

China has simplified its foreign exchange rules for foreign direct investment. And that’s welcome news… (DLA Piper)

The surge of federal oversight over compounding pharmacies continues… (Duane Morris)

Global equity capital markets are essentially closed to juniors and mid-cap players in the mining industry… (White & Case)

Joining the (private equity) club? Don’t set yourself up for a lawsuit… (Pepper Hamilton)

For more legal updates, visit JD Supra Law News>>